Obermatt
See Similar Stocks →

Albemarle

NYQ:ALB · US0126531013
ChemicalsLarge

360

62
EV / EBIT76
Price / Owner Earnings100
Owner Earnings Yield1
Dividend Yield49
Price/Sales16
EV / Gross Profit2
Price/Book36
Return on Capital5
Cash Return on Capital14
Return on Equity11
EBIT Margin17
Gross Profitability1
Accruals95
Owner Earnings Margin14
Sales growth88
Profit Growth88
Long-Term EPS Growth77
Reinvestment59
Price momentum97
Debt load89
Refinancing19
Debt Payback1
Liquidity41
Analyst ratings31
Opinion Changes50
Price Target Upside98
Market mood7
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Albemarle clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryChemicals
SizeLarge
TypePublic Company
ExchangeNYSE
Founded1993
Employees2,992
Websitealbemarle.com
ISINUS0126531013
Last UpdateApr 2, 2026
Indices
S&P 500 (USA)
Themes
CleanTechClimateTechPollution ControlBattery Energy Storage System (BESS)Urban MiningClean EnergyEnergy StorageLithiumChemicalConstructionCustomer ServiceManufacturingPharmaceutical

Description

Albemarle Corporation (Albemarle) operates in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. The company’s purpose is to enable a more resilient world. The company partners to pioneer new w…

Analysis

Weak and unloved

Albemarle Corporation scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is solid; the safety picture is adequate. The company scores 8/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
48
2023202420252026

All-time high

48

Jun 2026

All-time low

15

Jan 2025

Average rank

37

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
16
36
22
3
Price/Earnings
67
1
91
5
Price/Book
36
81
64
32
Dividend Yield
49
65
27
22
Value (overall)
25
43
47
6

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Albemarle with its peers
Olin
NYQ:OLN
16
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →
ASP Isotopes
NAQ:ASPI
22
CountryUSA
IndustryChemicals
SizeSmall
Full Stock Analysis →
Cabot
NYQ:CBT
75
CountryUSA
IndustryChemicals
SizeLarge
Full Stock Analysis →
NewMarket
NYQ:NEU
68
CountryUSA
IndustryChemicals
SizeLarge
Full Stock Analysis →
Quaker Chemical
NYQ:KWR
35
CountryUSA
IndustryChemicals
SizeLarge
Full Stock Analysis →
Trinseo
NYQ:TSE
5
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →